Aim: To compare the dimensional outcomes of horizontal augmentation with the retentive‐flap technique using particulate and cross‐linked collagenated bone substitutes. Materials and Methods: This two‐centre, two‐arm randomized clinical trial investigated 69 subjects: 34 in the particulate group and 35 in the collagenated group. Patients were randomly assigned to receive single implant placement with simultaneous guided bone regeneration (GBR) using either particulate deproteinized porcine bone material (DPBM) or cross‐linked collagenated DPBM. Quantitative evaluations were conducted for horizontal width, augmented area, and augmented volume in both hard and soft tissue dimensions. Results: Immediately after surgery, the collagenated group exhibited higher hard tissue dimensions in terms of horizontal width and augmented area. After 4 months, the difference between the two groups decreased to a non‐significant level, mainly attributable to the high shrinkage rate of the collagenated group (32.32 [20.79] %) compared to the particulate group (19.90 [14.33] %). No significant difference was observed regarding the soft tissue contour analyses between the two groups after 4 months. Conclusions: There were no significant differences between cross‐linked collagenated and particulated DPBMs regarding the dimensional outcomes of horizontal augmentation with the retentive‐flap technique. The high resorption rate of the collagenated bone substitute negates its initial superiority in both radiographic and soft tissue dimensions (no. KCT0005348).
24 February 2026 in Clinical Oral Implants Research
Aim: To identify patient‐ and clinician‐reported outcomes (PROs and ClinROs) and methods of assessment in clinical trials involving short and/or standard‐length and/or zygomatic implants supporting maxillary implant overdentures (IODs). Materials and Methods: A systematic search was conducted in PubMed, EMBASE, Scopus, Web of Science CENTRAL, and National clinical trial register for articles published between January 1, 2014, and March 23, 2024. Studies that included PROs and ClinROs for implant therapy in patients with edentulous maxillae were eligible, and study quality was appraised using the Cochrane Risk of Bias 2 tool, Newcastle‐Ottawa Scale, or Joanna Briggs Institute Critical tool. Results: A total of 2331 articles were screened, resulting in 21 studies representing 14 patient cohorts with 462 participants and 2140 implants. Two studies used short implants (6 mm) with standard‐length implants, while the remaining 19 studies focused exclusively on standard‐length implants (7–14 mm); none included zygomatic implants. Patient‐reported outcome measures (PROMs) varied widely: Oral Health Impact Profile questionnaires and visual analogue scales were each used in eight studies, and eleven studies relied on unstandardized questionnaires. Implant survival rate was the most frequently used ClinRO, included in all but one study. Subjective ClinROs based on clinician perception were absent in all studies. Conclusions: Although PROMs were frequently employed in clinical trials, the lack of standardization hinders meaningful comparisons across studies. While objective ClinROs were commonly reported, subjective ClinROs reflecting clinicians' perceptions were notably absent.
21 October 2025 in Journal of Clinical Periodontology
Aim: To evaluate treatment outcomes following implantoplasty or the use of rotating titanium brushes in the surgical therapy of peri‐implantitis. Materials and Methods: Thirty patients with peri‐implantitis in need of surgical treatment were enrolled in a 12‐month randomised clinical trial with a non‐inferiority set‐up. Surface decontamination was performed using either titanium brushes (test group) or implantoplasty (control group). Clinical and radiographic parameters as well as patient‐reported outcomes (Oral Health Impact Profile‐14; OHIP‐14) were evaluated. Results: At 12 months, the composite outcome was achieved in 6/15 implants in the test group and in 4/15 in the control group. Probing pocket depth (PPD) values decreased by 3.6 ± 1.5 mm (test) and 3.3 ± 1.2 mm (control), demonstrating non‐inferiority of the test procedure. Additional bone loss was observed in the control group (0.7 ± 1.2 mm), while bone levels remained unchanged in the test group (0.0 ± 0.6 mm). Baseline PPD ( p = 0.044) and the presence of an adjacent implant affected by peri‐implantitis ( p = 0.033) were relevant factors for pocket closure (PPD ≤ 5 mm at 12 months). Time for surface decontamination was significantly less in the test (3 min 1 s) when compared to the control group (5 min 27 s) ( p = 0.006). OHIP‐14 scores were statistically indifferent. Conclusion: Both groups showed favourable outcomes, demonstrating non‐inferiority of titanium brushes to implantoplasty. Trial Registration: The trial was registered with the Clinical Research Information Service of the National Research Institute of Health (South Korea), no. KCT007900. ( https://cris.nih.go.kr/cris/search/detailSearch.do?seq=23346&search_page=L )
To identify patient- and clinician-reported outcomes (PROs and ClinROs) and methods of assessment in clinical trials involving short and/or standard-length and/or zygomatic implants supporting maxillary implant overdentures (IODs). A systematic search was conducted in PubMed, EMBASE, Scopus, Web of Science CENTRAL, and National clinical trial register for articles published between January 1, 2014, and March 23, 2024. Studies that included PROs and ClinROs for implant therapy in patients with edentulous maxillae were eligible, and study quality was appraised using the Cochrane Risk of Bias 2 tool, Newcastle-Ottawa Scale, or Joanna Briggs Institute Critical tool. A total of 2331 articles were screened, resulting in 21 studies representing 14 patient cohorts with 462 participants and 2140 implants. Two studies used short implants (6 mm) with standard-length implants, while the remaining 19 studies focused exclusively on standard-length implants (7-14 mm); none included zygomatic implants. Patient-reported outcome measures (PROMs) varied widely: Oral Health Impact Profile questionnaires and visual analogue scales were each used in eight studies, and eleven studies relied on unstandardized questionnaires. Implant survival rate was the most frequently used ClinRO, included in all but one study. Subjective ClinROs based on clinician perception were absent in all studies. Although PROMs were frequently employed in clinical trials, the lack of standardization hinders meaningful comparisons across studies. While objective ClinROs were commonly reported, subjective ClinROs reflecting clinicians' perceptions were notably absent.